Evaluation of the Effect of Medication Therapy Management Model in Hospitalized Patients with Type 2 Diabetes
Objective:To evaluate the effect of medication therapy management model for hospitalized patients with diabetes mellitus type 2(T2DM),and to explore a pharmacy service model suitable for China.Methods:The study subjects were T2DM patients admitted to the Department of Endocrinology,Beijing Tongren Hospital,from October 1,2022 to September 30,2023.Patients who satisfied the standard of alloxia were divided into clinical pharmacist management group and routine management group.In clinical pharmacist management group,Clinical pharmacist management group would also be deeply involved in the patients'individualized treatment program,detailed medication guidance and health education,and follow up regularly after discharge,in addition to routinely carrying out the review of medical prescriptions,discharge education,and medication counseling.Comparison of the two groups of patients'blood glucose,blood pressure,blood lipid control at 3 months after discharge.Results:Total of 221 patients were included in the clinical pharmacist management group,including 98 females and 123 males,with a median age of 59(43.5,67.0)years,and whereas 217 patients in the routine management group,74 females and 143 males included,with a median age of 55(42.0,56.0)years.The optimal application rates of metformin,GLP-1Ra,SGLT2i,and statins in the clinical pharmacist management group were significantly higher than those in the routine management group(P＜0.05),and further subgroup analyses showed that the application rates of preferably used drugs were significantly higher in ASCVD and DKD patients in the clinical pharmacist management group compared with those in routine management group(P＜0.05);after discharge,the compliance rates of HbAlc,blood pressure,and low density lipoprotein cholesterol(LDL-c)in the clinical pharmacist management group were significantly higher than routine management group(P＜0.05);however,there was no significant difference in inpatient drug costs and adverse reactions(P＞0.05).Conclusion:Clinical pharmacists carried out pharmaceutical care in the mode of medication therapy management model for inpatient with type 2 diabetes mellitus,is beneficial to the optimization of medication therapy and the improvement of clinical treatment effects.
type 2 diabetesclinical pharmacistmedication therapy managementcohort study
NETL
NSTL
万方数据
